Debt Investors

THE MATERIALS YOU ARE SEEKING TO ACCESS (I) DO NOT CONSTITUTE OR FORM A PART OF ANY OFFER OR SOLICITATION TO PURCHASE SECURITIES AND (II) ARE NOT DIRECTED AT AND MAY NOT BE VIEWED BY OR DISTRIBUTED TO PERSONS

 

  • IN THE UNITED STATES OR WHO ARE U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE SECURITIES ACT);

  • IN THE EUROPEAN ECONOMIC AREA WHO ARE NOT “QUALIFIED INVESTORS” WITHIN THE MEANING OF REGULATION (EU) 2017/1129 (THE “PROSPECTUS REGULATION”);

  • IN THE UNITED KINGDOM WHO ARE NOT QUALIFIED INVESTORS (I) WHO HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS FALLING WITHIN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (THE “ORDER”), OR WHO FALL WITHIN ARTICLE 49(2)(A) TO (D) OF THE ORDER, OR (II) TO WHOM IT MAY OTHERWISE LAWFULLY BE COMMUNICATED (ALL SUCH PERSONS TOGETHER BEING REFERRED TO AS “RELEVANT PERSONS”); OR

  • LOCATED IN AUSTRALIA, CANADA OR JAPAN; OR

  • LOCATED IN A JURISDICTION WHERE IT IS UNLAWFUL TO DO SO;

BY CLICKING THE BUTTON BELOW LABELLED “I AGREE”, YOU ARE CERTIFYING THAT (A) YOU ARE NOT IN THE UNITED STATES OR A U.S. PERSON; (B) IF YOU ARE IN THE EUROPEAN ECONOMIC AREA OR IN THE UK, YOU ARE A “QUALIFIED INVESTOR”; (C) IF YOU ARE IN THE UNITED KINGDOM, YOU ARE A “RELEVANT PERSON”; (D) YOU ARE NOT ACCESSING THIS WEBSITE FROM AUSTRALIA, CANADA OR JAPAN; AND YOU ARE NOT LOCATED IN A JURISDICTION WHERE IT IS UNLAWFUL TO DO SO; AND (E) IF YOU ARE ACTING AS A FINANCIAL INTERMEDIARY, THE SECURITIES ACQUIRED BY YOU AS A FINANCIAL INTERMEDIARY IN THE OFFER HAVE NOT BEEN ACQUIRED ON A NON-DISCRETIONARY BASIS ON BEHALF OF, NOR HAVE THEY BEEN ACQUIRED WITH A VIEW TO THEIR OFFER OR RESALE TO, ANY PERSON IN CIRCUMSTANCES WHICH MAY GIVE RISE TO AN OFFER OF ANY SECURITIES TO THE PUBLIC OTHER THAN THEIR OFFER OR RESALE IN ANY MEMBER STATE OF THE EEA OR IN THE UK WHICH HAS IMPLEMENTED THE PROSPECTUS REGULATION TO QUALIFIED INVESTORS (AS DEFINED IN THE PROSPECTUS REGULATION).

 

IF YOU CANNOT SO CERTIFY, YOU MUST CLICK THE BUTTON LABELLED “I DISAGREE” OR OTHERWISE EXIT THIS WEBSITE.

 

BY ACCESSING THE MATERIALS ON THIS WEBSITE, YOU SHALL BE DEEMED TO HAVE MADE THE ABOVE REPRESENTATIONS AND CONSENTED TO DELIVERY BY ELECTRONIC TRANSMISSION.

More from Lundbeck

Investor Relations 

Detailed information related to Lundbeck’s financial performance. Contact Palle Olesen, VP Investor Relations. + 45 3083 2426 

About Us 

A global pharmaceutical company specialized in brain diseases.

Press

Lundbeck seeks an open dialogue with the press. For general press enquiries, please call + 45 3643 4000